Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 28NIH 13INDUSTRY 10NETWORK 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 1

Interventions

Leucovorin 4Fluorouracil 3Oxaliplatin 2Laparoscopy 2Cetuximab 2Capecitabine 2tislelizumab 1ferric maltol 1envafolimab 1Tranexamic Acid 1Surgical Procedures, Operative 1Ropivacaine 1Propofol 1Preoperative Exercise 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Nitrous Oxide 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Motivational Interviewing 1Isoflurane 1Irinotecan 1Ipilimumab 1Immunohistochemistry 1HMPL-013 1Folfox protocol 1Filgrastim 1Fentanyl 1Epinephrine 1Endoscopic Mucosal Resection 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Colonic Neoplasms × Folfox protocol × Clear all
NCT00070213 2021-09-27

Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Medical Research Council

Phase 3 Completed
460 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡